Mayhew BS[au] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Add to Collections

Selection:

Create a new collection
Add to an existing collection

Name your collection:

Name must be less than 100 characters

Choose a collection:

Unable to load your collection due to an error
Please try again

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
1999	1
2000	1
2021	0

2 results

Results by year

Page 1

Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation.

Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, Hall SD. Jones DR, et al. Among authors: mayhew bs. J Pharmacol Exp Ther. 1999 Sep;290(3):1116-25. J Pharmacol Exp Ther. 1999. PMID: 10454485

An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.

Mayhew BS, Jones DR, Hall SD. Mayhew BS, et al. Drug Metab Dispos. 2000 Sep;28(9):1031-7. Drug Metab Dispos. 2000. PMID: 10950845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results